Adaptive Sample Size Calculations in Group Sequential Trials
From MaRDI portal
Publication:4668352
DOI10.1111/J.0006-341X.1999.01286.XzbMATH Open1059.62671OpenAlexW2069607843WikidataQ47213254 ScholiaQ47213254MaRDI QIDQ4668352FDOQ4668352
Authors: Walter Lehmacher, Gernot Wassmer 
Publication date: 18 April 2005
Published in: Biometrics (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1111/j.0006-341x.1999.01286.x
Recommendations
- Development of Adaptive Group Sequential Procedure for Changing Sample Size
- Adaptive group sequential designs for clinical trials: combining the advantages of adaptive and of classical group sequential approaches
- scientific article; zbMATH DE number 3923914
- Modification of Sample Size in Group Sequential Clinical Trials
- Data-Driven Analysis Strategies for Proportion Studies in Adaptive Group Sequential Test Designs
Applications of statistics to biology and medical sciences; meta analysis (62P10) Sequential statistical analysis (62L10)
Cites Work
- Discrete Sequential Boundaries for Clinical Trials
- A Two-Sample Test for a Linear Hypothesis Whose Power is Independent of the Variance
- Evaluation of Experiments with Adaptive Interim Analyses
- Approximately Optimal One-Parameter Boundaries for Group Sequential Trials
- Designed Extension of Studies Based on Conditional Power
- Title not available (Why is that?)
- On the Power of Fisher's Combination Test for Two Stage Sampling in the Presence of Nuisance Parameters
- Group Sequential Monitoring with Arbitrary Inspection Times
- A Comparison of Two Methods for Adaptive Interim Analyses in Clinical Trials
Cited In (80)
- Blinded sample size recalculation in multiple composite population designs with normal data and baseline adjustments
- Bayesian group sequential enrichment designs based on adaptive regression of response and survival time on baseline biomarkers
- Adaptive enrichment designs with a continuous biomarker
- Discussion on “Adaptive enrichment designs with a continuous biomarker” by N. Stallard
- Monitoring Continuous Long-Term Outcomes in Adaptive Designs
- A two-stage group-sequential design for delayed treatment responses with the possibility of trial restart
- Adding experimental treatment arms to multi-arm multi-stage platform trials in progress
- Point estimation, confidence intervals, and \(P\)-values for optimal adaptive two-stage designs with normal endpoints
- Sample size adaptation designs and efficiency comparison with group sequential designs
- Two-stage randomized clinical trials with a right-censored endpoint: comparison of frequentist and Bayesian adaptive designs
- A variational approach to optimal two-stage designs
- Adaptive multiarm multistage clinical trials
- Adaptive enrichment trials: what are the benefits?
- On the efficiency of adaptive sample size design
- Optimal planning of adaptive two-stage designs
- Point estimation for adaptive trial designs. I: A methodological review
- Comments on ``Adaptive sample size modification in clinical trials: start small then ask for more?
- A new conditional performance score for the evaluation of adaptive group sequential designs with sample size recalculation
- Statistical tests for two-stage adaptive seamless design using short- and long-term binary outcomes
- Improving adaptive seamless designs through Bayesian optimization
- Exact change point detection with improved power in small‐sample binomial sequences
- New results on optimal conditional error functions for adaptive two-stage designs
- A conditional error function approach for adaptive enrichment designs with continuous endpoints
- Adaptive Design for Censored Survival Data Adjusting for Covariates
- Estimation of a Parameter and Its Exact Confidence Interval Following Sequential Sample Size Reestimation Trials
- Procedure for determining sample size at each stage in group sequential test
- Internal pilots for observational studies
- Are Flexible Designs Sound?
- On group sequential procedures under variance heterogeneity
- Adaptive and nonadaptive group sequential tests
- Adapting sample size calculations to repeated measurements in clinical trials
- Adaptive designs with arbitrary dependence structure based on Fisher's combination test
- Exact Confidence Bounds Following Adaptive Group Sequential Tests
- A MORE GENERAL CRITERION FOR SUBSET SELECTION IN MULTIPLE LINEAR REGRESSION
- Adaptive Multivariate Global Testing
- GROUP SEQUENTIAL TESTS WITH OUTCOME-DEPENDENT TREATMENT ASSIGNMENT
- Power, sample size and adaptation considerations in the design of group sequential clinical trials
- An evaluation of inferential procedures for adaptive clinical trial designs with pre-specified rules for modifying the sample size
- Adaptive confidence intervals of desired length and power for normal means
- Partition testing in confirmatory adaptive designs with structured objectives
- Adaptive modifications of hypotheses after an interim analysis
- Sequential tests for noninferiority and superiority
- Adaptive designs for subpopulation analysis optimizing utility functions
- Interim Analysis and Sample Size Reassessment
- P-value adjustment in sequential clinical trials
- Optimal two-stage group-sequential designs
- p-Value calculation for multi-stage additive tests
- On sample size and inference for two-stage adaptive designs
- A sample size adjustment procedure for clinical trials based on conditional power
- A note on the shape of sample size functions of optimal adaptive two-stage designs
- A simple algorithm for designing group sequential clinical trials
- Generalized Likelihood Ratio Statistics and Uncertainty Adjustments in Efficient Adaptive Design of Clinical Trials
- Modification of Sample Size in Group Sequential Clinical Trials
- Statistical Inference for Self‐Designing Clinical Trials with a One‐Sided Hypothesis
- Adaptive designs with arbitrary dependence structure
- Design aspects of COVID‐19 treatment trials: Improving probability and time of favorable events
- Adaptive dose-finding: Proof of concept with type I error control
- Title not available (Why is that?)
- Basic concepts of group sequential and adaptive group sequential test procedures
- α-Investing: a Procedure for Sequential Control of Expected False Discoveries
- Adaptive group sequential designs for clinical trials: combining the advantages of adaptive and of classical group sequential approaches
- Optimal Conditional Error Functions for the Control of Conditional Power
- Optimization of adaptive designs with respect to a performance score
- Improving the Flexibility and Efficiency of Phase II Designs for Oncology Trials
- Development of Adaptive Group Sequential Procedure for Changing Sample Size
- Confidence intervals for the selected population in randomized trials that adapt the population enrolled
- Sequential monitoring of response-adaptive randomized clinical trials with sample size re-estimation
- SEAMLESS PHASE II/III CLINICAL TRIALS WITH COVARIATE ADAPTIVE RANDOMIZATION
- Self-designing two-stage trials to minimize expected costs
- Monitoring Clinical Trials with Multiple Arms
- Sample size re-estimation for confirmatory two-stage flexible multi-arm trial with normal outcomes
- Statistical inference in adaptive group sequential trials with the standardized mean difference as effect size
- Trendtests with adaptive scoring.
- Interim Design Modifications in Time-to-Event Studies
- Data-Driven Analysis Strategies for Proportion Studies in Adaptive Group Sequential Test Designs
- A comparison of methods for constructing confidence intervals after phase II/III clinical trials
- Maximum type 1 error rate inflation in multiarmed clinical trials with adaptive interim sample size modifications
- An approach to the conditional error rate principle with nuisance parameters
- Adaptive Design and Estimation in Randomized Clinical Trials with Correlated Observations
- Recursive Combination Tests
This page was built for publication: Adaptive Sample Size Calculations in Group Sequential Trials
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q4668352)
